Le Lézard
Classified in: Health
Subjects: POLITICS, HEALTH

"Interoperability Saves Lives" Offers Solutions For Alberta's Healthcare System


EDMONTON, Alberta, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Canada's healthcare system is facing critical challenges, putting the health and safety of Canadians at risk. While a response to the current crisis is urgent, there are also opportunities to reinforce a strong foundation for the future of the healthcare system.

The Alberta Virtual Care Coordinating Body (AVCCB) is a non-partisan and broad collective of Alberta healthcare stakeholders, including patient and Indigenous representatives, focused on providing evidence-based strategies to support better patient care and improved health outcomes. The AVCCB focuses on "virtual care" which is the sharing of health information between members of health care teams, across location or time, to enable quality patient care and improved health and wellbeing.

The AVCCB has just released their highly anticipated report "Interoperability Saves Lives", focusing on the importance of health data exchange or interoperability. Healthcare teams cannot function safely if they lack access to information, cannot communicate effectively, or cannot share information needed to provide quality care. Interoperability is essential for high-functioning virtual care, and indeed all health care system function.

"It is not a secret that our health care system is deeply stressed and failing Canadians on some levels," said Dr. Ewan Affleck, Chair of the AVCCB, physician and Canadian expert in data governance and health informatics. "Information is essential when making decisions about a patient's care," says Dr. Affleck, "running a health-care system with fragmented information is like flying a plane with hidden instruments."

The "Interoperability Saves Lives" report focuses on a holistic, patient-centred approach to health information system design. "As this report highlights, we must implement health data interoperability without delay," said Tim Murphy, Vice-President Health, Alberta Innovates and Chair of the Data Interoperability subcommittee. "We can no longer endure a fractured healthcare system that provides uncoordinated services, elevated costs, stifled innovation and suboptimal care. Albertans and Canadians deserve better."

The core recommendations of the report include:

Teri Price, co-chair of the AVCCB and co-founder and Executive Director of Greg's Wings, a nationally recognized, not-for-profit that focuses on supporting improvement in our healthcare systems, understands the impact of the lack of access or sharing patient information all too well. In 2012, her brother Greg Price died of complications after testicular cancer surgery. An independent review of his case by the Health Quality Council of Alberta found that the delay or lack of sharing of critical information between those responsible for his care, contributed to his death. All the missteps in his case meant it took over 400 days from his initial symptoms until he received treatment.

"While there have been some changes in the ten years since Greg's death there is still a need to create the conditions where patients will no longer fall through the cracks," says Price. "Safe and quality care requires teamwork and until we have a system that enables a patient's care team to seamlessly share and access information needed to make safe decisions, there is a very real safety risk that will continue to cause harm."

The full "interoperability Saves Lives" report is available at albertavirtualcare.org.



These press releases may also interest you

at 04:09
A news report from China Daily: The 2024 ZGC Forum in Beijing showcased a wide range of latest technological innovations. The event ran from April 25 to 29 and comprised 128 activities, including forums and conferences, technology exchanges,...

at 04:05
Alvotech , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. , disclosed today that under the...

at 03:38
Preparations for the planned phase 2b study continue according to plan after the completed Type C meeting with the FDA, strengthened by the fact that the median time to progression with fostrox + Lenvima increased to 7 months. January ? March...

at 03:05
The European Academy of Allergy and Clinical...

at 03:00
BioWorldtm published by  Clarivate Plc , a leading global provider of transformative intelligence, explores the growing investment in CAR T therapy development in mainland China in a new series titled "China's CAR T market comes of age." The report...

at 03:00
SynOx Therapeutics Limited ("SynOx" or the "Company"), the late-stage clinical biopharmaceutical company developing emactuzumab...



News published on and distributed by: